Retraction: Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma

PDF  |  How to cite

Oncotarget. 2023; 14:242-242. https://doi.org/10.18632/oncotarget.28396

Metrics: PDF 610 views  |   ?  

Bing Zhu1,*, Jian-Ru Yang2,*, Yang Jia3, Pei Zhang1, Lin Shen1, Xiao-Long Li1, Jing Li1 and Bing Wang1

1Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China
2Central Laboratory, Handan Infectious Diseases Hospital, Handan 056002, P.R. China
3Department of General Practice, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, P.R. China
*These authors have contributed equally to this work

Published: March 24, 2023

Copyright: © 2023 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget is retracting this article at the request of the Scientific Integrity office. Similarities were found between images in this article and in other articles:

  1. BMC Cancer (2017), https://doi.org/10.1186/s12885-017-3132-9
  2. Disease Markers (2017), https://doi.org/10.1155/2017/6136401

Reader concerns were initially reported in a Pubpeer thread (https://pubpeer.com/publications/1D3EFEEE1E55BFC3B47D193AEFECE6).

Image analysis performed by the Oncotarget Scientific Integrity Office confirmed the findings of fraudulent image duplication. All authors have agreed to this retraction.

Original article: Oncotarget. 2017; 8:1139777–113986. DOI: https://doi.org/10.18632/oncotarget.23048

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28396